Acebright (India) Pharma Pvt. Ltd. Rating Rationales / Reports

Title MID: 94292 08-Sep-2025 Issuer did not cooperate; Based on best available information; View Report MID: 83150 20-Sep-2024 Issuer did not cooperate; Based on best available information; View Report MID: 74457 22-Sep-2023 Issuer did not cooperate; Based on best available information; Long Term Rating Downgraded to BWR C; Short Term Rating Reaffirmed; View Report MID: 66026 23-Sep-2022 Issuer did not cooperate; Based on best available information; Short Term Rating Reaffirmed; Long Term Rating Downgraded to BWR B -; View Report MID: 53805 22-Sep-2021 Issuer did not cooperate; Based on best available information; Long Term Rating Downgraded to BWR B; Short Term Rating Reaffirmed; View Report MID: 43659 21-Sep-2020 Issuer did not cooperate; Based on best available information; Short Term Rating Reaffirmed; Long Term Rating Downgraded to BWR B +; View Report MID: 31892 26-Jul-2019 Issuer did not cooperate; Based on best available information; Outstanding Ratings Reaffirmed; View Report MID: 16295 29-Dec-2016 Long Term (Not Reviewed);Short Term (Not Reviewed); View Report MID: 9843 09-Jun-2015 Outstanding Ratings Reaffirmed; View Report MID: 37 08-Jan-2014 Long Term Rating BWR BB -/Stable Assigned; Short Term Rating BWR A4 Assigned; View Report